Three-year experience with GLP-2 analog in intestinal rehabilitation for pediatric-onset short bowel syndrome.

Pediatr Surg Int · 2025 · PMC12394345 · PMID 40875041

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Following three years of GLP-2 analog therapy, six of the 13 patients showed a trend towards reduced stool frequency, with improved stool consistency exhibited in all patients.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.